New osteoporosis med shown to reduce fractures in men, women

(Daily Mail) UPDATED 2009-08-13

According to two new studies, a twice-yearly jab with the osteoporosis Prolia (denosumab) may reduce spinal and hip fractures. The studies, published in the New England Journal of Medicine, included data on 8,000 post-menopausal women, as well as 900 men who had bone thinning due to prostate cancer treatment. Researchers found that the risk of hip fracture was cut by 40 percent, with a 20 percent reduction in risk of other broken bones in women, while men on the drug increased their bone mass by 5.6 percent. An advisory committee for the U.S. Food and Drug Administration is meeting this week to discuss safety issues concerning the medication. Read full story >

See all Osteoporosis News